ICO Hospitalet, Catalan Institute of Oncology

Barcelona 199-203

0 studies enrolling now · 1 studies all time

What they study most

Neuroendocrine Tumors

Studies at this site

• Lutetium 177Lu-Edotreotide Versus Best Standard of Care in Well-differentiated Aggressive Grade-2 and Grade-3 GastroEnteroPancreatic NeuroEndocrine Tumors (GEP-NETs) - COMPOSE — Running, not enrolling